Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
E.WirthJ.et al (2020)
On average, patients can expect to lose between 5% to 15% of their body weight, with some patients losing more over time
Vision loss is typically permanent, though it is often stable after onset
Patients appetite may return to normal after discontinuing the medication, contributing to weight regain
The SUSTAIN-6 trial, which evaluated the cardiovascular outcomes of Semaglutide in patients with type 2 diabetes, found that it significantly reduced the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death
US$ 24.25
US$ 25.65
US$ 26.51
US$ 28.05
US$ 23.61
US$ 24.90
